MOESM7 of Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells
2019-10-11T05:37:29Z (GMT) by
Additional file 7. Figure S7. Western blot analysis showing that pretreatment of PAD2 knockdown (a) or miR-125b-5p overexpression (b) MCF7/TamR cells with 10 ÎźM MHY1485 abolished the inhibitory effect of docetaxel on Rps6 activation. GAPDH served as loading control; shPAD2: PAD2 knockdown MCF7/TamR cells; miR-125b-5p: miR-125b-5p overexpression MCF7/TamR cells; Doc: docetaxel; PBS was used as a control.